Target intelligence / Profile preview

Aconitate hydratase (Aconitase)

Target
Aconitase
Molecular classification
Enzyme, Iron-sulfur protein, Hydratase
01

Overview

Aconitate hydratase (commonly known as aconitase) is an iron-sulfur enzyme that catalyzes the stereospecific isomerization of citrate to isocitrate via the intermediate cis-aconitate, a critical step in the citric acid (TCA) cycle[1][3][4][6]. Aconitase contains a [4Fe-4S] iron-sulfur cluster essential for its catalytic activity and is widely expressed from bacteria to humans, with both mitochondria-specific (ACO2) and cytosolic (ACO1) isoforms in eukaryotes. By enabling the TCA cycle, aconitase plays a central role in aerobic energy metabolism. The enzyme is sensitive to oxidative stress due to its iron-sulfur prosthetic group, and its activity is a marker for mitochondrial health. Dysfunction or inhibition of aconitase contributes to metabolic diseases, neurodegenerative conditions, and cancer cell metabolism adaptations[1][4][6].

Other names
AconitaseCitrate hydro-lyaseACO1 (gene, isoform in plants)ACO2 (mitochondrial isoform in humans)
02

Mechanism of action

Inhibitors block the isomerization of citrate to isocitrate by binding the active site or disrupting the iron-sulfur cluster[1][4]. Drugs that target the enzyme block cellular energy metabolism and the TCA cycle.

03

Biological functions

Citric acid (tricarboxylic acid, TCA, Krebs) cycleCatalyzes isomerization of citrate to isocitrate via cis-aconitateCellular metabolismRegulation of energy production
04

Disease associations

CancerNeurodegenerative diseaseOther (e.g., metabolic disorders, mitochondrial dysfunction)
05

Safety considerations

Inhibition leads to impaired mitochondrial function and energy failure, raising concerns for systemic toxicity.Iron-sulfur cluster instability leads to enzyme inactivation in oxidative environments.
06

Interacting drugs

Fluoroacetate (toxic inhibitor in vivo for TCA cycle studies; metabolized to fluorocitrate, which inhibits aconitase)

1 more in the full profile.

07

Biomarkers

Decreased aconitase activity can serve as a marker of mitochondrial dysfunction and oxidative stress in neurodegenerative diseases.Altered aconitase levels or activity have been studied in cancer and aging.

Beyond the preview

Go deeper on Aconitate hydratase (Aconitase).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aconitate hydratase (Aconitase).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call